Microcystic Lymphatic Malformation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Microcystic Lymphatic Malformation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT05948943

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

The main purpose of this study in participants with PIK3CA-mutated LyM is to assess the change in radiological response and symptom severity upon treatment with…

United States232 participantsStarted 2023-11-24

Treatment: Alpelisib, Placebo

All recent trials (9 shown)

Active — Not RecruitingPhase 2

NCT02978625

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-mela…

This phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refract…

United States68 participantsStarted 2017-09-27

Treatment: Biopsy Procedure, Biospecimen Collection

Active — Not RecruitingPhase 3

NCT06239480

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malforma…

SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcysti…

United States51 participantsStarted 2024-07-31

Treatment: QTORIN 3.9% Rapamycin Anhydrous Gel

Microcystic Lymphatic Malformation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

All recent trials (9 shown)

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-mela…

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malforma…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

All recent trials (9 shown)

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-mela…

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malforma…

Topical Sirolimus in Cutaneous Lymphatic Malformations

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malform…

Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations